» Articles » PMID: 35978628

Effect and Related Mechanism of Platelet-Rich Plasma on the Osteogenic Differentiation of Human Adipose-Derived Stem Cells

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2022 Aug 18
PMID 35978628
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Human adipose-derived stem cells (hADSCs) are ideal seed cells for the regeneration of alveolar bone defects. Platelet-rich plasma (PRP), which is rich in growth factors, promotes tissue repair. The purpose of the present study was to investigate whether PRP promotes the osteogenic differentiation of hADSCs and to perform high-throughput sequencing to explore the possible mechanism.

Methods: hADSCs were divided into the three following groups: CON group, OM group, and PRP group. Osteogenesis was detected by Alizarin Red staining on day 14. Total RNA was extracted from the OM and PRP groups for high-throughput sequencing. The target genes of the differentially expressed osteogenic-related miRNAs were predicted, and combined miRNA/mRNA analysis was then performed. The mRNA and protein expression levels of hsa-miR-212-5p, type 1 cannabinoid receptor (CNR1), alkaline phosphatase (ALP), Runx2, osteocalcin (OCN), and collagen 1 A1 (COL1A1) in the OM and PRP groups were detected by qRT-PCR and Western blot analyses. The binding between hsa-miR-212-5p and CNR1 was detected by a dual-luciferase reporter assay.

Results: Both the OM and PRP groups exhibited enhanced proliferation of hADSCs, and the differences at 48 h and 72 h were statistically significant ( < 0.05). The PRP group had significantly more calcium nodules than the CON group ( < 0.05). Through high-throughput sequencing analysis, differential miRNA and mRNA expression profiles were obtained. During hADSC osteogenesis, the expression of hsa-miR-212-5p was downregulated, and the expression of CNR1 was upregulated. hsa-miR-212-5p was found to bind directly to the 3' UTR of CNR1.

Conclusions: The present findings indicated that downregulation of hsa-miR-212-5p and upregulation of CNR1 may be involved in the process by which PRP promotes the osteogenic differentiation of hADSCs.

Citing Articles

Platelet Concentrates Preconditioning of Mesenchymal Stem Cells and Combined Therapies: Integrating Regenerative Strategies for Enhanced Clinical Applications.

Li X, Xiao H, Wang Z, Tang X, Yu X, Pan Y Cell Transplant. 2024; 33:9636897241235460.

PMID: 38506426 PMC: 10956156. DOI: 10.1177/09636897241235460.


Unveiling Polysomal Long Non-Coding RNA Expression on the First Day of Adipogenesis and Osteogenesis in Human Adipose-Derived Stem Cells.

Bonilauri B, Ribeiro A, Spangenberg L, Dallagiovanna B Int J Mol Sci. 2024; 25(4).

PMID: 38396700 PMC: 10888724. DOI: 10.3390/ijms25042013.


Osteogenically committed hUCMSCs-derived exosomes promote the recovery of critical-sized bone defects with enhanced osteogenic properties.

Li S, Rong Q, Zhou Y, Che Y, Ye Z, Liu J APL Bioeng. 2024; 8(1):016107.

PMID: 38327715 PMC: 10849773. DOI: 10.1063/5.0159740.


Apoptosis Related Human Wharton's Jelly-Derived Stem Cells Differentiation into Osteoblasts, Chondrocytes, Adipocytes and Neural-like Cells-Complete Transcriptomic Assays.

Stefanska K, Nemcova L, Blatkiewicz M, Pienkowski W, Rucinski M, Zabel M Int J Mol Sci. 2023; 24(12).

PMID: 37373173 PMC: 10297881. DOI: 10.3390/ijms241210023.

References
1.
Zheng Z, Liu J . GDNF-ADSCs-APG embedding enhances sciatic nerve regeneration after electrical injury in a rat model. J Cell Biochem. 2019; 120(9):14971-14985. DOI: 10.1002/jcb.28759. View

2.
Zhang C, Ma J, Chen G, Fu D, Li L, Li M . Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese. Osteoporos Int. 2015; 26(12):2803-10. DOI: 10.1007/s00198-015-3195-x. View

3.
Le A, Enweze L, DeBaun M, Dragoo J . Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med. 2018; 11(4):624-634. PMC: 6220007. DOI: 10.1007/s12178-018-9527-7. View

4.
Altamura S, Di Martino A, Andriolo L, Boffa A, Zaffagnini S, Cenacchi A . Platelet-Rich Plasma for Sport-Active Patients with Knee Osteoarthritis: Limited Return to Sport. Biomed Res Int. 2020; 2020:8243865. PMC: 7013341. DOI: 10.1155/2020/8243865. View

5.
Gupta S, Paliczak A, Delgado D . Evidence-based indications of platelet-rich plasma therapy. Expert Rev Hematol. 2020; 14(1):97-108. DOI: 10.1080/17474086.2021.1860002. View